What did Accolade, Inc. pay for 2nd.MD?

Accolade, Inc. acquired 2nd.MD for $420.1M in 2021, equivalent to 12.00x revenue. Target revenue was approximately $35.0M.

2nd.MD is a healthcare it business.

What multiple did Accolade, Inc. pay for 2nd.MD?

12.00x revenue, based on disclosed deal value of $420.1M and disclosed financials.

M&A TRANSACTION · 2021

2nd.MD acquired by Accolade, Inc.

$420.1M· 12.00x revenue

Target

2nd.MD

Acquirer

Accolade, Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$35.0M

EBITDA

—

Deal Value

$420.1M

EV/EBITDA

—

Context

This $420.1M acquisition of 2nd.MD by Accolade, Inc. sits in the healthcare it sub-vertical. Accolade, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the 2nd.MD acquisition.

Citation: ExitValue.ai. (2021). 2nd.MD acquired by Accolade, Inc.. https://exitvalue.ai/deals/2ndmd-acquired-by-accolade-inc-hc-2021-0109